MEDICAL DEVICES
The Central Drugs Standard Control Organization and the US Food and Drug Administration are the parties to the MoU. Sources claimed the two nations would focus on information exchange to help in capacity building.
The talks were expected to centre around medical devices, mostly the pricing regulation that India has on devices like cardiac stents. The US medical devices lobby is unhappy with the price regulations and proposals of trade margin rationalisation of devices and has indicated that such regulations hamper the introduction of innovative devices here.